Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response, Proc Natl Acad Sci, vol.102, pp.14723-14728, 2005. ,
Lymphoid neogenesis in chronic rejection: the murderer is in the house, Curr Opin Immunol, vol.18, pp.576-579, 2006. ,
The impact of c4d pattern and donorspecific antibody on graft survival in recipients requiring indication renal allograft biopsy, Am J Transplant, vol.9, pp.2758-2767, 2009. ,
Impact of donorspecific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques, Transplantation, vol.71, pp.1106-1112, 2001. ,
Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection, J Immunol, vol.169, pp.4620-4627, 2002. ,
Effector mechanisms in transplant rejection, Immunol Rev, vol.196, pp.51-64, 2003. ,
Antibody-mediated organ-allograft rejection, Nat Rev Immunol, vol.5, pp.807-817, 2005. ,
The role of antibodies in transplantation, Transplant Rev (Orlando), vol.23, pp.191-198, 2009. ,
Effect of antibodies on endothelium, Am J Transplant, vol.9, pp.2459-2465, 2009. ,
Characterization of a human B lymphocyte-specific antigen, J Immunol, vol.125, pp.1678-1685, 1980. ,
B cell-targeted therapies in autoimmunity: rationale and progress, F1000 Biol Rep, vol.1, p.39, 2009. ,
Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection, Transplan tation, vol.87, pp.1837-1841, 2009. ,
Targeting CD22 reprograms B-cells and reverses autoimmune diabetes, Diabetes, vol.57, pp.3013-3024, 2008. ,
Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet alloand autoimmune responses, Diabetes, vol.61, pp.155-165, 2012. ,
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus, Arthritis Res Ther, vol.8, 2006. ,
A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys, Am J Pathol, vol.168, pp.476-489, 2006. ,
BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact, Proc Natl Acad Sci, vol.105, pp.15517-15522, 2008. ,
In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice, J Immunol, vol.181, pp.8133-8144, 2008. ,
BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses, Eur J Immunol, vol.34, pp.2750-2759, 2004. ,
Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFF. Transplantation, vol.93, pp.676-685, 2012. ,
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial, Arthritis Res Ther, vol.14, p.33, 2012. ,
,
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus, Arthritis Rheum, vol.63, 2011. ,
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc, Science, vol.320, pp.373-376, 2008. ,
Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production, Am J Transplant, vol.9, pp.201-209, 2009. ,
Proteasome inhibitor-based therapy for antibody-mediated rejection, Kidney Int, vol.81, pp.1067-1074, 2012. ,
Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients, Am J Transplant, vol.11, pp.2405-2413, 2011. ,
Regulatory B cells: evidence, developmental origin and population diversity, Mol Immunol, vol.48, pp.1-8, 2010. ,
DOI : 10.1016/j.molimm.2010.09.010
Immune regulatory function of B cells, Annu Rev Immunol, vol.30, pp.221-241, 2012. ,
Regulation of cellular antibody synthesis effect of adoptively transferred antibody-producing spleen cells on cellular antibody synthesis, J Immunol, vol.101, pp.439-445, 1968. ,
B-cell suppression of delayed hypersensitivity reactions, Nature, vol.251, pp.550-551, 1974. ,
Suppressor cells in normal immunisation as a basic homeostatic phenomenon, Nature, vol.248, pp.612-614, 1974. ,
Experimental autoimmune encephalomyelitis induction in genetically B celldeficient mice, J Exp Med, vol.184, pp.2271-2278, 1996. ,
Prevention of arthritis by interleukin 10-producing B cells, J Exp Med, vol.197, pp.489-501, 2003. ,
TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production, J Clin Immunol, vol.25, pp.29-40, 2005. ,
Intravenous transfusion of BCRactivated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner, J Immunol, vol.179, pp.7225-7232, 2007. ,
Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice, J Exp Med, vol.186, pp.1749-1756, 1997. ,
Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice, J Immunol, vol.190, pp.1158-1168, 2013. ,
Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8 ,
, + T cell function in vitro, J Leukoc Biol, vol.93, pp.811-818, 2013.
Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice, J Clin Invest, vol.121, pp.4268-4280, 2011. ,
Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand, Proc Natl Acad Sci, vol.92, pp.9560-9564, 1995. ,
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo, J Immunol, vol.161, pp.5331-5337, 1998. ,
Postoperative administration of donor B cells induces rat kidney allograft acceptance: lack of association with Th2 cytokine expression in long-term accepted grafts, Transplantation, vol.73, pp.1123-1130, 2002. ,
Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes, J Immunol, vol.178, pp.6028-6032, 2007. ,
Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice, J Clin Invest, vol.121, pp.3645-3656, 2011. ,
Anti-CD45RB/ anti-TIM-1-induced tolerance requires regulatory B cells, Am J Transplant, vol.12, pp.2072-2078, 2012. ,
Induction of donor-specific allograft tolerance by short-term treatment with LF15-0195 after transplantation. Evidence for a direct effect on T-cell differentiation, Am J Transplant, vol.2, pp.745-757, 2002. ,
Role for thymic and splenic regulatory CD4 ,
, + T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment, J Immunol, vol.168, pp.5058-5069, 2002.
Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile, Am J Transplant, vol.11, pp.429-438, 2011. ,
Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype, Kidney Int, vol.78, pp.503-513, 2010. ,
Identification of a B cell signature associated with renal transplant tolerance in humans, J Clin Invest, vol.120, pp.1836-1847, 2010. ,
Development of a crossplatform biomarker signature to detect renal transplant tolerance in humans, J Clin Invest, vol.120, pp.1848-1861, 2010. ,
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance, Proc Natl Acad Sci, vol.104, pp.15448-15453, 2007. ,
Unique B cell differentiation profile in tolerant kidney transplant patients, Am J Transplant, vol.14, pp.144-155, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00974748
Cutting edge: IL-10-producing regulatory B cells in early human pregnancy, Am J Reprod Immunol, vol.70, pp.448-453, 2013. ,
B-cell-depleting induction therapy and acute cellular rejection, N Engl J Med, vol.360, pp.2683-2685, 2009. ,
Novel suppressive function of transitional 2 B cells in experimental arthritis, J Immunol, vol.178, pp.7868-7878, 2007. ,
The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals, J Immunol, vol.182, pp.7459-7472, 2009. ,
Interleukin-35 induces regulatory B cells that suppress autoimmune disease, Nat Med, vol.20, pp.633-641, 2014. ,
From the regulatory functions of B cells to the identification of cytokineproducing plasma cell subsets, Curr Opin Immunol, vol.28, pp.77-83, 2014. ,
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients, Immunity, vol.32, pp.129-140, 2010. ,
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, pp.530-541, 2011. ,
Human regulatory B cells combine phenotypic and genetic hallmarks with a distinct differentiation fate, J Immunol, vol.193, pp.2258-2266, 2014. ,
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD, Blood, vol.124, pp.2034-2045, 2014. ,
Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10, Eur J Immunol, vol.22, pp.711-717, 1992. ,
IL-10-producing regulatory B cells (B10 cells) in autoimmune disease, Arthritis Res Ther, vol.15, 2013. ,
A regulatory B cell subset with a unique CD1dhiCD5 + phenotype controls T cell-dependent inflammatory responses, Immunity, vol.28, pp.639-650, 2008. ,
Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells, J Immunol, vol.184, pp.3321-3325, 2010. ,
Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen, J Exp Med, vol.194, pp.1691-1697, 2001. ,
Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells, Proc Natl Acad Sci, vol.110, pp.2199-2208, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00845005
Bar-Or A. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis, J Immunol, vol.178, pp.6092-6099, 2007. ,
Human T cells induce their own regulation through activation of B cells, J Autoimmun, vol.36, pp.228-238, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00771265
B-1 cells: the lineage question revisited, Immunol Rev, vol.175, pp.9-22, 2000. ,
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity, J Clin Invest, vol.105, pp.1731-1740, 2000. ,
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis, J Clin Invest, vol.114, pp.427-437, 2004. ,
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation, Immunity, vol.16, pp.219-230, 2002. ,
B cells regulate autoimmunity by provision of IL-10, Nat Immunol, vol.3, pp.944-950, 2002. ,
Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice, J Immunol, vol.184, pp.4789-4800, 2010. ,
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function, Leukemia, vol.27, pp.170-182, 2013. ,
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases, Nature, vol.507, pp.366-370, 2014. ,
B-type suppression: a role played by "regulatory B cells" or "regulatory plasma cells"?, Eur J Immunol, vol.44, pp.1251-1257, 2014. ,
Innate response activator B cells protect against microbial sepsis, Science, vol.335, pp.597-601, 2012. ,
Acquisition of a multifunctional IgA + plasma cell phenotype in the gut, Nature, vol.481, pp.199-203, 2012. ,
,
, + B cells to maintain tolerance to islet autoantigens, Diabetes, vol.64, pp.158-171, 2015.
B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation, Blood, vol.108, pp.2712-2719, 2006. ,
Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21, J Immunol, vol.183, pp.1838-1845, 2009. ,
CD5 + B cells from individuals with systemic lupus erythematosus express granzyme B, Eur J Immunol, vol.40, pp.2060-2069, 2010. ,
Activated mouse B cells lack expression of granzyme B, J Immunol, vol.188, pp.3886-3892, 2012. ,
, , vol.4
, + T cellderived IL-21 and deprivation of CD40 signaling favor the in vivo development of granzyme B-expressing regulatory B cells in HIV patients, J Immunol, vol.194, pp.3768-3777, 2015.
Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties, J Am Soc Nephrol, vol.2, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02148982
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities, J Immunol, vol.192, pp.6083-6091, 2014. ,
Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells, Cancer Res, vol.73, pp.2468-2479, 2013. ,
Activated B cells express functional Fas ligand, Eur J Immunol, vol.26, pp.721-724, 1996. ,
Reduced Fas ligand-expressing splenic CD5 + B lymphocytes in severe collagen-induced arthritis, Arthritis Res Ther, vol.11, 2009. ,
Killer B lymphocytes: the evidence and the potential, Inflamm Res, vol.58, pp.345-357, 2009. ,
Constitutive expression of Fas (Apo-1/ CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance, Blood, vol.90, pp.12-20, 1997. ,
Epstein-Barr virus induces Fas (CD95) in T cells and Fas ligand in B cells leading to T-cell apoptosis, Blood, vol.94, pp.3439-3447, 1999. ,
Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection, AIDS Res Hum Retroviruses, vol.13, pp.1031-1038, 1997. ,
Spontaneous in vivo retrovirusinfected T and B cells, but not dendritic cells, mediate antigenspecific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL, Virology, vol.346, pp.287-300, 2006. ,
Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice, J Immunol, vol.167, pp.1081-1089, 2001. ,
B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice, J Leukoc Biol, vol.78, pp.1052-1059, 2005. ,
The critical role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen, Transplantation, vol.78, pp.799-806, 2004. ,
Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells, Eur J Immunol, vol.28, pp.1492-1498, 1998. ,
Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage, Eur J Immunol, vol.28, pp.973-982, 1998. ,
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells, J Cell Physiol, vol.205, pp.246-252, 2005. ,
PD-1 and its ligands in tolerance and immunity, Annu Rev Immunol, vol.26, pp.677-704, 2008. ,
Expression of programmed death 1 ligands by murine T cells and APC, J Immunol, vol.169, pp.5538-5545, 2002. ,
PD-L2 is a second ligand for PD-1 and inhibits T cell activation, Nat Immunol, vol.2, pp.261-268, 2001. ,
Role of PD-L1 and PD-L2 in allergic diseases and asthma, Allergy, vol.66, pp.155-162, 2011. ,
PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding, Eur J Immunol, vol.37, pp.2405-2410, 2007. ,
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy, Nature, vol.521, pp.94-98, 2015. ,
Fcgamma receptors as regulators of immune responses, Nat Rev Immunol, vol.8, pp.34-47, 2008. ,
Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG, Nature, vol.316, pp.452-457, 1985. ,
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation, Science, vol.313, pp.670-673, 2006. ,
Identification of a receptor required for the anti-inflammatory activity of IVIG, Proc Natl Acad Sci, vol.105, pp.19571-19578, 2008. ,
Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway, Nature, vol.475, pp.110-113, 2011. ,
Fc-glycosylation of IgG1 is modulated by B-cell stimuli, Mol Cell Proteomics, vol.10, 2011. ,
Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation, J Immunol, vol.176, pp.5950-5957, 2006. ,
Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells, J Immunol, vol.186, pp.5569-5579, 2011. ,
Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model, J Allergy Clin Immunol, vol.125, pp.1114-1124, 2010. ,
Efficient induction and expansion of human alloantigenspecific CD8 regulatory T cells from naive precursors by CD40-activated B cells, J Immunol, vol.183, pp.3742-3750, 2009. ,
CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells, Cell Mol Immunol, vol.7, pp.44-50, 2010. ,
Accommodation: preventing injury in transplantation and disease, J Immunol, vol.172, pp.5143-5148, 2004. ,
Protective genes expressed in endothelial cells: a regulatory response to injury, Immunol Today, vol.18, issue.97, pp.1129-1137, 1997. ,
Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment, Nat Med, vol.3, pp.196-204, 1997. ,
New evidence for a role of allograft accommodation in long-term tolerance, Transplantation, vol.82, pp.1185-1193, 2006. ,
Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation, J Immunol, vol.172, pp.3553-3563, 2004. ,
Accommodation, Immunol Today, vol.20, pp.434-437, 1999. ,
Expression of heme oxygenase-1 can determine cardiac xenograft survival, Nat Med, vol.4, pp.1073-1077, 1998. ,
Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs, Immunol Rev, vol.184, pp.275-285, 2001. ,
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses, J Allergy Clin Immunol, vol.131, pp.1204-1212, 2013. ,
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure, J Exp Med, vol.205, pp.2887-2898, 2008. ,
Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study, Am J Transplant, vol.15, pp.1384-1391, 2015. ,
B cells display an abnormal distribution and an impaired suppressive function in patients with chronic antibody-mediated rejection, Kidney Int, vol.85, pp.590-599, 2014. ,
Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes, J Immunol, vol.186, pp.614-620, 2011. ,
B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naive B cells, Am J Transplant, vol.12, pp.1784-1792, 2012. ,
An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation, Am J Transplant, vol.12, pp.919-931, 2012. ,
B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates, Nat Med, vol.13, pp.1295-1298, 2007. ,
CD24(hi)CD27 + and plasmablastlike regulatory B cells in human chronic graft-versus-host disease, Blood, vol.125, pp.1830-1839, 2015. ,
Induction of IL-10-producing CD1dhighCD5+ regulatory B cells following Babesia microti-infection, PLoS One, vol.7, p.46553, 2012. ,